Pre-Annual General Meeting Information • Jun 3, 2025
Pre-Annual General Meeting Information
Open in ViewerOpens in native device viewer
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to any aspects of the proposals referred to in this document or as to the action you should take, you are recommended to seek your own financial advice from your stockbroker, bank manager, solicitor, accountant, other professional adviser or other independent financial adviser duly authorised under the Financial Services and Markets Act 2000 if you are resident in the UK or, if not, from another appropriately authorised independent financial adviser.
If you have sold or otherwise transferred all of your shares in Medcaw Investments plc, please send this document, and the accompanying form of proxy or form of instruction, to the purchaser or transferee of those shares or to the stockbroker, bank or other agent through whom the sale or transfer was effected, for delivery to the purchaser or transferee.

(Incorporated and registered in England and Wales with registered number 13078596)
Notice of the annual general meeting of the Company (the "Annual General Meeting" or "AGM") to be held at 4.00p.m. on 26 June 2025 at Eccleston Yards, 25 Eccleston Place, London, United Kingdom, SW1W 9NF is set out at the end of this document. A form of proxy for use at the Annual General Meeting accompanies this document and, to be valid, must be completed and returned to the Company at Share Registrars Limited at 3 The Millennium Centre, Crosby Way, Farnham, Surrey, GU9 7XX as soon as possible but in any event to be received not later than 4.00 p.m. on 24 June 2024 or 48 hours (excluding non-business days) before any adjourned meeting.

2 June 2025
Dear Shareholder,
Please find enclosed the Notice of our AGM ("Notice of AGM") to be held at 4.00 p.m. on 26 June 2025 at Eccleston Yards, 25 Eccleston Place, London, United Kingdom, SW1W 9NF. The Notice of AGM details a number of resolutions proposed by the Company's Board of Directors (the "Board"), a proxy form for you to complete and explanatory notes which contain information on the resolutions to be proposed at the AGM.
Resolutions 1 to 4 in the Notice of AGM will all be proposed as Ordinary Resolutions. This means that, for each of those Resolutions to be passed on a poll, members representing a simple majority of the total voting rights of the members voting (in person or by proxy), being more than 50%, must vote in favour of the Resolution.
Resolutions 5 and 6 in the Notice of AGM will be proposed as a Special Resolution. For Special Resolutions to be passed on a poll, members representing not less than 75% of the total voting rights of the members voting (in person or by proxy) must vote in favour of the Resolution.
Further details of the resolutions are set out in below.
Shareholders are encouraged to attend the meeting in person. The directors will give a business update to shareholders and answer relevant questions at the beginning of the AGM, after which the formal business as set out in the Notice of AGM will be considered.
Shareholders are strongly encouraged to submit a proxy vote in advance of the AGM. You are strongly encouraged to use your right to appoint the Chair of the AGM as your proxy to attend the meeting and vote on your behalf. Please vote online at to www.shareregistrars.uk.com, clicking on the "Proxy Vote" button and then following the on-screen instructions, or by filling in the Form of Proxy or the Form of Instruction sent with this Notice and returning it by post to the Company's Registrars as soon as possible at Share Registrars Limited, 3 The Millennium Centre, Crosby Way, Farnham, Surrey GU9 7XX. The Registrars must receive your Form of Proxy by 4.00 pm. on 24 June 2024. For instructions on proxy voting, please see the notes to the Notice of AGM for information on pages 6 to 8.
The results will be announced via a Regulatory News Service and on the Company's website as soon as practicable following the AGM.
At the AGM, shareholders will be asked to approve the resolutions detailed below.
Company law requires the Directors to present the Annual Report and Accounts of the Company to the Company's shareholders in respect of each financial year.
The Board recommends to shareholders that RPG Crouch Chapman LLP be re-appointed as the Company's auditor to hold office until the conclusion of the next Annual General Meeting and to authorise the Board, through the Audit Committee, to determine their remuneration.
In accordance with the Company's Articles, Mr Marcus Yeoman will retire by rotation, and being eligible, offers himself up for re-election. Biographical information for Mr Marcus Yeoman can be found on the Company's website: www.medcaw-invest.com.
The Company is seeking the flexibility to issue or grant options over or otherwise dispose of shares in the capital of the Company ("shares") and other relevant securities of the Company. The Companies Act 2006 provides that Directors shall only allot shares with the authority of shareholders in general meeting.
Resolution 4 will be proposed as an ordinary resolution for the renewal of the Directors' general authority to issue shares in the Company and to grant rights to subscribe for or to convert any security into shares in the Company up to 22,000,000 Ordinary Shares in the Company, or an aggregate nominal amount of £220,000, representing approximately 100% of the current issued share capital of the Company. This authority is in substitution for all existing authority to issue shares in the Company or to grant rights to subscribe for or to convert any securities into shares in the Company.
This authority will expire at the end of the next AGM of the Company or 15 months after the resolution is passed, whichever is earlier, and it is the directors' intention to seek renewals and/or further authorities to disapply pre-emption rights in subsequent AGMs of the Company.
Under the Articles, where new Ordinary Shares are proposed to be issued for cash, they must first be offered to existing shareholders in proportion to their existing holdings. There may be occasions, however, where the directors may need the flexibility to issue Ordinary Shares without a fully pre-emptive offer in order to take advantage of business opportunities as they arise. Therefore Resolution 5 seeks authority for the directors to allot 22,000,000 Ordinary Shares in the Company, or an aggregate nominal amount of £220,000, (equal to approximately 100% of the issued voting share capital) for cash as if the pre-emption rights set out in the Articles did not apply to such allotment.
This authority will expire at the end of the next AGM of the Company or 15 months after the resolution is passed, whichever is earlier, and it is the directors' intention to seek renewals and/or further authorities to disapply pre-emption rights in subsequent AGMs of the Company.
The Directors are seeking approval for the adoption of new articles of association (a copy of which are appended to this Notice) (the "New Articles") for the reasons set out below. Please note that the below is a summary of the principal differences between: (a) the Company's current articles of association (the "Current Articles"); and (b) the New Articles only and is not intended as a comprehensive report of all differences between them. Shareholders are advised to review the Current Articles and the New Articles in full and take legal advice, where appropriate, as to the effect of the proposed adoption of the New Articles.
The Company's Ordinary Shares are admitted to the equity shares (shell companies) category of the UK Financial Conduct Authority's Official List. Pursuant to the new Listing Rules published by the UK's Financial Conduct Authority (the "Listing Rules") (in particular UKLR 13.2.1R), the constitution of a shell company must provide that, if the shell company has not completed an initial transaction (as defined in the Listing Rules) ("Initial Transaction") within 24 months from admission, it will cease operations on the date that is 24 months from the date of admission (the "Initial Transaction Constitution Requirement"). However, the shell company is entitled to provide for certain extensions to this deadline of 24 months in its constitution, being the ability to extend it by 12 months up to three times subject to Shareholder approval, which can be extended for a further period of up to six months in specified circumstances (the "Extensions").
The Directors are therefore proposing that the Company adopts the New Articles that provide for (amongst other things) the Initial Transaction Constitution Requirement and the flexibility for Shareholders to approve the Extensions at the relevant time.
Your Board believes that the resolutions contained in the Notice of AGM are in the best interests ofthe Company and its shareholders as a whole. Accordingly, the Board recommends that you vote in favour of each of the resolutions to be proposed at the Annual General Meeting, as your Directors on the Board intend to do in respect of their own shareholdings in the Company.
The Board looks forward to reporting to you on the business of the Company at the Annual GeneralMeeting.
Yours faithfully,
Marcus Yeoman Non-Executive Chairman
Notice is given that the Annual General Meeting of Medcaw Investments PLC (the "Company") will be held at Eccleston Yards, 25 Eccleston Place, London, United Kingdom, SW1W 9NF on 26 June 2025 at 4.00p.m. to consider the following resolutions, of which resolutions 1 to 4 will be proposed as ordinary resolutions and resolutions 5 and 6 as special resolutions:
By Order of the Board Registered Office: Orana Corporate LLP Eccleston Yards
25 Eccleston Place London SW1W 9NF
Company Secretary 2 June 225
and in each case, the proxy appointment must be received by Share Registrars Limited by 4.00p.m. on 24 June 2025 (or, if the AGM is adjourned, no later than 48 hours (excluding any part of a day that is not a working day) before the time of any adjourned meeting). A shareholder that appoints a person to act on its behalf under any power of attorney or other authority and wishes to use method (a), (b) or (c) must return such power of attorney or other authority to Share Registrars Limited, 3 The Millennium Centre, Crosby Way, Farnham, Surrey GU9 7XX prior to using such method and in any event by 4.00p.m. on 24 June 2025 (or, if the AGM is adjourned, no later than 48 hours (excluding any part of a day that is not a working day) before the time of any adjourned meeting).
determined by the timestamp applied to the message by the CREST Applications Host) from which Share Registrars Limited is able to retrieve the message by enquiry to CREST in the manner prescribed by CREST. After this time, any change of instructions to proxies appointed through CREST should be communicated to the appointee through other means.
Where you have appointed a proxy using the hard-copy Form of Proxy or Form of Instruction and would like to change the instructions using another hard-copy proxy form, please contact Share Registrars Limited, 3 The Millennium Centre, Crosby Way, Farnham, Surrey GU9 7XX.
The revocation notice must be received by Share Registrars Limited no later than 4.00pm. on 24 June 2025 (or, if the AGM is adjourned, no later than 48 hours (excluding any part of a day that is not a working day) before the time of any adjourned meeting).
Please be advised that due to the circumstances already set out, if you choose to terminatea proxy instruction, as you will not be able to attend the meeting in person you will not be entitled to vote.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.